Hépato-Gastro & Oncologie Digestive
MENUFilgotinib, a new JAK inhibitor for ulcerative colitis Volume 29, issue 1, January 2022
Export citation
Citation of this article, in the « Vancouver » format:
Mathieu Uzzan. Filgotinib, a new JAK inhibitor for ulcerative colitis. Hépato-Gastro & Oncologie Digestive. 2022;29(1):103-106. doi:10.1684/hpg.2021.2286